Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 3Serotonin Syndrome 2Pancreatic Neoplasms 1Biliary Tract Neoplasms 1

Interventions

telotristat ethyl 2telotristat 1pasireotide 1lanreotide 1alpha-methyltryptophan 1Random Allocation 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Serotonin Syndrome × telotristat ethyl × Clear all
NCT03453489 2025-04-10

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
4 enrolled 7 charts

Serotonin Syndrome

NCT03223428 2024-07-24

RELAX

TerSera Therapeutics LLC

Completed
223 enrolled 16 charts
EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡